Veradigm - 15 Year Stock Price History | MDRX
Historical daily share price chart and data for Veradigm since 2011 adjusted for splits and dividends. The latest closing stock price for Veradigm as of June 17, 2026 is 4.80.
- The all-time high Veradigm stock closing price was 23.09 on April 01, 2022.
- The Veradigm 52-week high stock price is 6.00, which is 25% above the current share price.
- The Veradigm 52-week low stock price is 3.00, which is 37.5% below the current share price.
- The average Veradigm stock price for the last 52 weeks is 4.70.
| Veradigm Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 4.6419 | 4.5500 | 5.1800 | 4.2000 | 4.8000 | 0.00% |
| 2025 | 4.9963 | 9.1000 | 9.7500 | 3.9000 | 4.8000 | -50.77% |
| 2024 | 9.1198 | 10.7500 | 11.2500 | 5.9900 | 9.7500 | -7.05% |
| 2023 | 13.4220 | 17.2200 | 19.5900 | 9.5100 | 10.4900 | -40.53% |
| 2022 | 17.9518 | 18.6100 | 23.0900 | 13.8500 | 17.6400 | -4.39% |
| 2021 | 16.2178 | 14.3300 | 18.7800 | 13.1900 | 18.4500 | 27.77% |
| 2020 | 8.7316 | 9.6900 | 14.6100 | 5.0200 | 14.4400 | 47.05% |
| 2019 | 10.4970 | 9.7800 | 12.2100 | 8.7600 | 9.8200 | 1.87% |
| 2018 | 12.8046 | 14.9800 | 16.0300 | 8.6400 | 9.6400 | -33.75% |
| 2017 | 12.7107 | 10.9300 | 14.9100 | 10.5300 | 14.5500 | 42.51% |
| 2016 | 12.7938 | 14.4300 | 14.6500 | 10.0000 | 10.2100 | -33.62% |
| 2015 | 13.4710 | 12.8500 | 15.5300 | 11.6100 | 15.3800 | 20.44% |
| 2014 | 15.1701 | 15.3900 | 19.4300 | 11.2300 | 12.7700 | -17.40% |
| 2013 | 13.7477 | 9.4100 | 16.2600 | 9.3700 | 15.4600 | 64.12% |
| 2012 | 13.4261 | 18.3100 | 21.4700 | 8.9900 | 9.4200 | -50.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |